Generating mouse models of degenerative diseases using Cre/lox-mediated in vivo mosaic cell ablation

Masato Fujioka, Hisashi Tokano, Keiko Shiina Fujioka, Hideyuki Okano, Albert S B Edge

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Most degenerative diseases begin with a gradual loss of specific cell types before reaching a threshold for symptomatic onset. However, the endogenous regenerative capacities of different tissues are difficult to study, because of the limitations of models for early stages of cell loss. Therefore, we generated a transgenic mouse line (Mos-iCsp3) in which a lox-mismatched Cre/lox cassette can be activated to produce a drug-regulated dimerizable caspase-3. Tissue-restricted Cre expression yielded stochastic Casp3 expression, randomly ablating a subset of specific cell types in a defined domain. The limited and mosaic cell loss led to distinct responses in 3 different tissues targeted using respective Cre mice: reversible, impaired glucose tolerance with normoglycemia in pancreatic β cells; wound healing and irreversible hair loss in the skin; and permanent moderate deafness due to the loss of auditory hair cells in the inner ear. These mice will be important for assessing the repair capacities of tissues and the potential effectiveness of new regenerative therapies.

Original languageEnglish
Pages (from-to)2462-2469
Number of pages8
JournalJournal of Clinical Investigation
Volume121
Issue number6
DOIs
Publication statusPublished - 2011 Jun 1

Fingerprint

Auditory Hair Cells
Glucose Intolerance
Alopecia
Deafness
Inner Ear
Caspase 3
Wound Healing
Transgenic Mice
Skin
Pharmaceutical Preparations
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Generating mouse models of degenerative diseases using Cre/lox-mediated in vivo mosaic cell ablation. / Fujioka, Masato; Tokano, Hisashi; Fujioka, Keiko Shiina; Okano, Hideyuki; Edge, Albert S B.

In: Journal of Clinical Investigation, Vol. 121, No. 6, 01.06.2011, p. 2462-2469.

Research output: Contribution to journalArticle

Fujioka, Masato ; Tokano, Hisashi ; Fujioka, Keiko Shiina ; Okano, Hideyuki ; Edge, Albert S B. / Generating mouse models of degenerative diseases using Cre/lox-mediated in vivo mosaic cell ablation. In: Journal of Clinical Investigation. 2011 ; Vol. 121, No. 6. pp. 2462-2469.
@article{00b56b6ac1d7482780ba6f816680365c,
title = "Generating mouse models of degenerative diseases using Cre/lox-mediated in vivo mosaic cell ablation",
abstract = "Most degenerative diseases begin with a gradual loss of specific cell types before reaching a threshold for symptomatic onset. However, the endogenous regenerative capacities of different tissues are difficult to study, because of the limitations of models for early stages of cell loss. Therefore, we generated a transgenic mouse line (Mos-iCsp3) in which a lox-mismatched Cre/lox cassette can be activated to produce a drug-regulated dimerizable caspase-3. Tissue-restricted Cre expression yielded stochastic Casp3 expression, randomly ablating a subset of specific cell types in a defined domain. The limited and mosaic cell loss led to distinct responses in 3 different tissues targeted using respective Cre mice: reversible, impaired glucose tolerance with normoglycemia in pancreatic β cells; wound healing and irreversible hair loss in the skin; and permanent moderate deafness due to the loss of auditory hair cells in the inner ear. These mice will be important for assessing the repair capacities of tissues and the potential effectiveness of new regenerative therapies.",
author = "Masato Fujioka and Hisashi Tokano and Fujioka, {Keiko Shiina} and Hideyuki Okano and Edge, {Albert S B}",
year = "2011",
month = "6",
day = "1",
doi = "10.1172/JCI45081",
language = "English",
volume = "121",
pages = "2462--2469",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Generating mouse models of degenerative diseases using Cre/lox-mediated in vivo mosaic cell ablation

AU - Fujioka, Masato

AU - Tokano, Hisashi

AU - Fujioka, Keiko Shiina

AU - Okano, Hideyuki

AU - Edge, Albert S B

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Most degenerative diseases begin with a gradual loss of specific cell types before reaching a threshold for symptomatic onset. However, the endogenous regenerative capacities of different tissues are difficult to study, because of the limitations of models for early stages of cell loss. Therefore, we generated a transgenic mouse line (Mos-iCsp3) in which a lox-mismatched Cre/lox cassette can be activated to produce a drug-regulated dimerizable caspase-3. Tissue-restricted Cre expression yielded stochastic Casp3 expression, randomly ablating a subset of specific cell types in a defined domain. The limited and mosaic cell loss led to distinct responses in 3 different tissues targeted using respective Cre mice: reversible, impaired glucose tolerance with normoglycemia in pancreatic β cells; wound healing and irreversible hair loss in the skin; and permanent moderate deafness due to the loss of auditory hair cells in the inner ear. These mice will be important for assessing the repair capacities of tissues and the potential effectiveness of new regenerative therapies.

AB - Most degenerative diseases begin with a gradual loss of specific cell types before reaching a threshold for symptomatic onset. However, the endogenous regenerative capacities of different tissues are difficult to study, because of the limitations of models for early stages of cell loss. Therefore, we generated a transgenic mouse line (Mos-iCsp3) in which a lox-mismatched Cre/lox cassette can be activated to produce a drug-regulated dimerizable caspase-3. Tissue-restricted Cre expression yielded stochastic Casp3 expression, randomly ablating a subset of specific cell types in a defined domain. The limited and mosaic cell loss led to distinct responses in 3 different tissues targeted using respective Cre mice: reversible, impaired glucose tolerance with normoglycemia in pancreatic β cells; wound healing and irreversible hair loss in the skin; and permanent moderate deafness due to the loss of auditory hair cells in the inner ear. These mice will be important for assessing the repair capacities of tissues and the potential effectiveness of new regenerative therapies.

UR - http://www.scopus.com/inward/record.url?scp=79957909838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957909838&partnerID=8YFLogxK

U2 - 10.1172/JCI45081

DO - 10.1172/JCI45081

M3 - Article

C2 - 21576819

AN - SCOPUS:79957909838

VL - 121

SP - 2462

EP - 2469

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -